Annovis Bio Inc
ANVS2.320USD
-0.030-1.28%
收盘 09/19, 16:00（美东）报价延迟15分钟
45.21M总市值
亏损市盈率 TTM
关于 Annovis Bio Inc 公司
Annovis Bio, Inc. 是一家临床阶段药物平台公司，致力于治疗神经退行性疾病，如阿尔茨海默病 (AD)、帕金森病 (PD) 和其他慢性神经退行性疾病。该公司正在开发其主要候选产品 Buntanetap，旨在治疗 AD、PD 和其他潜在的慢性神经退行性疾病。Buntanetap 是一种合成的小分子口服脑渗透性化合物。其候选产品 ANVS405 是一种静脉注射药物，正在开发用于急性适应症，专注于保护创伤性脑损伤 (TBI) 和/或中风后的大脑。ANVS405 与 Buntanetap 是同一种化合物，用于治疗急性头部和脑部创伤。ANVS301 是一种口服药物，正在开发用于提高 AD 和痴呆症后期的认知能力。ANVS301 被观察到通过将错误数量从六个减少到三个来改善高龄大鼠的记忆力和学习能力。
公司简介
公司代码ANVS
公司名称Annovis Bio Inc
上市日期Jan 29, 2020
CEODr. Maria L. Maccecchini, Ph.D.
员工数量8
证券类型Ordinary Share
年结日Jan 29
公司地址101 Lindenwood Drive, Suite 225
城市MALVERN
上市交易所NYSE Consolidated
国家United States of America
邮编19355
电话14848753192
网址https://www.annovisbio.com/
公司代码ANVS
上市日期Jan 29, 2020
CEODr. Maria L. Maccecchini, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Independent Chairman of the Board
Independent Chairman of the Board
1.70M
+2.02%
Dr. Maria L. Maccecchini, Ph.D.
Dr. Maria L. Maccecchini, Ph.D.
President, Chief Executive Officer, Founder, Acting Chief Financial Officer, Director
President, Chief Executive Officer, Founder, Acting Chief Financial Officer, Director
--
--
Dr. Claudine E. Bruck, Ph.D.
Dr. Claudine E. Bruck, Ph.D.
Independent Director
Independent Director
--
--
Mr. Reid S. Mccarthy
Mr. Reid S. Mccarthy
Independent Director
Independent Director
--
--
Mr. Mark White
Mr. Mark White
Director, Chief Business Officer
Director, Chief Business Officer
--
--
Dr. Mike Christie, Ph.D.
Dr. Mike Christie, Ph.D.
Vice President - Process Chemistry
Vice President - Process Chemistry
--
--
Ms. Eve Damiano
Ms. Eve Damiano
Senior Vice President - Regulatory
Senior Vice President - Regulatory
--
--
Dr. Cheng Fang, Ph.D.
Dr. Cheng Fang, Ph.D.
Senior Vice President - Research and Development
Senior Vice President - Research and Development
--
--
Ms. Melissa Gaines
Ms. Melissa Gaines
Senior Vice President - Clinical Operations
Senior Vice President - Clinical Operations
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Independent Chairman of the Board
Independent Chairman of the Board
1.70M
+2.02%
Dr. Maria L. Maccecchini, Ph.D.
Dr. Maria L. Maccecchini, Ph.D.
President, Chief Executive Officer, Founder, Acting Chief Financial Officer, Director
President, Chief Executive Officer, Founder, Acting Chief Financial Officer, Director
--
--
Dr. Claudine E. Bruck, Ph.D.
Dr. Claudine E. Bruck, Ph.D.
Independent Director
Independent Director
--
--
Mr. Reid S. Mccarthy
Mr. Reid S. Mccarthy
Independent Director
Independent Director
--
--
Mr. Mark White
Mr. Mark White
Director, Chief Business Officer
Director, Chief Business Officer
--
--
Dr. Mike Christie, Ph.D.
Dr. Mike Christie, Ph.D.
Vice President - Process Chemistry
Vice President - Process Chemistry
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 8月16日 周六
更新时间: 8月16日 周六
持股股东
股东类型
持股股东
持股股东
占比
Hoffman (Michael B)
8.74%
Maccecchini (Maria-Luisa)
5.72%
Heights Capital Management, Inc.
5.13%
The Vanguard Group, Inc.
3.58%
Geode Capital Management, L.L.C.
0.94%
其他
75.89%
持股股东
持股股东
占比
Hoffman (Michael B)
8.74%
Maccecchini (Maria-Luisa)
5.72%
Heights Capital Management, Inc.
5.13%
The Vanguard Group, Inc.
3.58%
Geode Capital Management, L.L.C.
0.94%
其他
75.89%
股东类型
持股股东
占比
Individual Investor
14.86%
Investment Advisor
11.44%
Investment Advisor/Hedge Fund
2.34%
Research Firm
0.51%
Hedge Fund
0.15%
Family Office
0.10%
Bank and Trust
0.05%
其他
70.56%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
103
5.98M
30.66%
-360.75K
2025Q1
104
5.95M
41.64%
-106.94K
2024Q4
93
4.41M
22.61%
-199.92K
2024Q3
85
4.03M
23.62%
-296.86K
2024Q2
80
3.84M
23.67%
-697.75K
2024Q1
77
3.92M
38.68%
-550.67K
2023Q4
77
3.92M
40.01%
-464.08K
2023Q3
81
3.83M
42.48%
-299.71K
2023Q2
104
3.90M
43.31%
-104.02K
2023Q1
106
3.34M
40.86%
-680.15K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Hoffman (Michael B)
1.67M
8.57%
+25.00K
+1.52%
Jun 13, 2025
Maccecchini (Maria-Luisa)
1.11M
5.72%
+46.00K
+4.31%
Jun 04, 2025
Heights Capital Management, Inc.
1.00M
5.13%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
647.92K
3.33%
+181.64K
+38.96%
Mar 31, 2025
Geode Capital Management, L.L.C.
152.61K
0.78%
+53.05K
+53.28%
Mar 31, 2025
Susquehanna International Group, LLP
127.70K
0.66%
+72.39K
+130.88%
Mar 31, 2025
Consilium Associates
97.82K
0.5%
-700.00
-0.71%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
99.49K
0.51%
-1.29K
-1.28%
Mar 31, 2025
White (Mark K.)
61.17K
0.31%
--
--
Apr 28, 2025
查看更多
持股ETF
更新时间: 9月2日 周二
更新时间: 9月2日 周二
机构名称
占比
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Micro-Cap ETF
占比0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%
DFA Dimensional US Sustainability Core 1 ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
